查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1469294

全球防褥瘡設備市場：依產品類型、最終用戶、地區：產業分析、規模、佔有率、成長、趨勢、預測（2024-2032）

Pressure Ulcer Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 465 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

持久性市場研究全面分析了全球抗褥瘡設備市場，並提供了有關市場動態、成長動力、課題和新興趨勢的重要見解。 該報告提供了獨家數據和統計數據，以預測 2024 年至 2032 年褥瘡控制設備市場的軌跡。

預估2024年全球壓瘡預防裝置市場規模將達55億美元，市場規模穩定擴張，複合年增長率為5.5%，預計2032年底產業估值將達84億美元。

關鍵見解

  • 褥瘡預防設備市場規模（2024 年）：55 億美元
  • 預計市值（2032 年）：84 億美元
  • 全球市場成長率（2024-2032）：5.5%

褥瘡預防器市場-調查範圍：

褥瘡防護裝置對於預防和治療褥瘡（也稱為壓瘡或褥瘡）至關重要。 這些設備包括床墊、靠墊、覆蓋物和特殊床，旨在重新分配身體壓力、減少摩擦和控制水分以防止壓瘡的發生。 該市場包括適用於各種醫療保健環境的各種產品，包括醫院、療養院和家庭護理。

全球壓瘡預防設備市場主要是由久坐不動、糖尿病和肥胖等慢性病盛行率不斷上升所推動的，這些疾病增加了壓瘡發生的風險。 此外，世界人口老化也促使對壓瘡預防和管理解決方案的需求不斷增長。 壓力分佈方面的技術進步，例如交變壓力床墊和低空氣損失床墊，透過提高患者舒適度和預防壓瘡的有效性，進一步推動市場成長。

推動市場成長的因素：

人口老化是市場成長的主要動力，因為老年人由於運動能力下降、皮膚變薄和併發症等因素更容易患壓瘡。 全球範圍內老年人口比例不斷增加，尤其是在已開發地區，對壓瘡預防和管理設備的需求預計將急劇增加。

此外，醫療基礎設施的進步和醫護人員對壓瘡預防意識的提高也有助於市場的擴張。 醫療機構越來越多地投資於先進的壓力分佈表面，以改善患者的治療效果並減輕與壓瘡治療相關的經濟負擔。

市場限制因素：

防褥瘡裝置市場面臨的主要課題之一是與先進的防褥瘡洩壓表面相關的高成本。 儘管這些設備具有出色的壓瘡預防和管理功能，但其高昂的初始成本可能會阻礙其採用，特別是在預算有限的醫療機構中。

此外，某些地區壓瘡預防設備的報銷政策不佳也阻礙了市場成長。 壓瘡預防和管理產品的保險範圍有限，導致患者無力負擔並阻礙了市場滲透。

市場機會：

對家庭醫療保健的日益關注和遠距醫療的興起為壓瘡預防設備市場提供了巨大的機會。 隨著醫療保健服務轉向更加分散的環境，對便攜式且易於家庭使用的壓力分佈表面的需求不斷增加。 製造商可以利用這一趨勢，開發適合家庭照顧者和患者需求的創新產品。

此外，將感測器和連接等智慧技術整合到壓瘡控制設備中，為遠端監控和數據驅動護理打開了大門。 具有監控功能的智慧壓力分佈表面使醫療保健提供者能夠追蹤患者的依從性、評估風險因素並主動幹預以改善臨床結果並減少再入院。

本報告涵蓋的主要問題

  • 哪些地區對壓瘡預防設備的需求最大？
  • 壓瘡預防與管理策略的趨勢是什麼？
  • 監管架構如何影響全球壓瘡控制設備的採用？
  • 推動壓瘡預防設備領域技術創新與市場拓展的主要公司有哪些？
  • 塑造壓瘡預防設備市場未來的新科技趨勢為何？

目錄

第 1 章執行摘要

第二章市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 包含和排除

第三章主要市場趨勢

  • 影響市場的主要趨勢
  • 產品創新/發展趨勢

第 4 章增值見解

  • 依地區劃分的洩壓裝置採用狀況分析
  • 依國家/地區劃分的疾病流行病學
  • 製造商的主要行銷和促銷策略
  • 價值鏈分析
  • 監管場景
  • 報銷情況
  • 杵分析
  • 波特的分析

第 5 章具體見解

  • 目前 PU 預防方法：依最終使用者環境（急診室/急診/ICU/HDU/手術室/照護設施/長期照護/居家照護環境）
  • 敷料在預防壓瘡方面的作用
  • 亞太國家預防壓瘡的證據與照護標準
  • 當前預防壓瘡的課題
  • 各地區壓瘡預防的主要趨勢

第六章市場背景

  • 宏觀經濟因素
  • 預測因子 - 相關性和影響
  • 市場動態

第 7 章 COVID-19 危機分析

  • 目前的 COVID-19 統計數據和未來的潛在影響
  • 當前 GDP 預測與預期影響
  • 新冠肺炎 (COVID-19) 與影響分析
    • 依地區
    • 依產品
    • 依階段
    • 依最終用戶

第 8 章全球壓瘡預防裝置市場 - 價格分析

  • 以產品劃分的區域價格分析
  • 世界平均價格分析基準

第九章全球壓瘡預防裝置市場需求（數量）分析（2019-2023）及預測（2024-2032）

  • 過去的市場規模分析（2019-2023 年）
  • 目前與未來的市場規模預測（2024-2032 年）
    • 年成長趨勢分析
    • 絕對利潤機會分析

第10章全球壓瘡預防裝置市場需求（數量或規模）分析（2019-2023）與預測（2024-2032）

  • 過往市值分析（2019-2023 年）
  • 當前與未來市場價值的預測（2024-2032 年）
    • 年成長趨勢分析

第11章全球壓瘡預防裝置市場分析（2019-2023）與預測（2024-2032）：依產品

  • 簡介/主要發現
  • 過去的市場規模分析：依產品（2019-2023 年）
  • 目前與未來的市場規模預測：依產品分類（2024-2032 年）
    • 床墊覆蓋層
    • 減壓床墊
    • 特殊床
    • 減壓墊
    • 交流壓力輪椅墊
    • 越野設備
    • 洩壓配件
    • 先進的傷口敷料
  • 依產品劃分的市場吸引力分析

第十二章全球壓瘡預防裝置市場分析（2019-2023）與預測（2024-2032）：依階段

  • 簡介/主要發現
  • 過去的市場規模分析：以階段（2019-2023 年）
  • 目前/未來市場規模分析/預測：依階段（2024-2032 年）
    • 第一階段
    • 第二階段
    • 第三階段
    • 第四階段
  • 分階段市場吸引力分析

第 13 章 全球壓瘡預防裝置市場分析（2019-2023 年）與預測（2024-2032 年）：依最終使用者劃分

  • 簡介/主要發現
  • 過去的市場規模分析：以最終用戶劃分（2019-2023 年）
  • 當前和未來的市場規模分析和預測：依最終用戶劃分（2024-2032 年）
    • 醫院
    • 長期照護中心
    • 護理設施
    • 居家照護環境
  • 最終用戶的市場吸引力分析

第14章依地區劃分的全球壓瘡預防裝置市場分析（2019-2023年）及預測（2024-2032年）

  • 簡介
  • 過去的市場規模分析：依地區劃分（2019-2023 年）
  • 目前與未來的市場規模分析與預測：依地區劃分（2024-2032 年）
    • 北美
    • 拉丁美洲
    • 歐洲
    • 南亞
    • 東亞
    • 大洋洲
    • 中東和非洲 (MEA)
  • 依地區劃分的市場吸引力分析

第十五章北美壓瘡預防裝置市場分析（2019-2023）與預測（2024-2032）

第十六章拉丁美洲壓瘡預防裝置市場（2019-2023）與預測（2024-2032）

第十七章歐洲壓瘡預防裝置市場（2019-2023）與預測（2024-2032）

第十八章南亞壓瘡預防裝置市場（2019-2023）與預測（2024-2032）

第十九章東亞壓瘡預防裝置市場（2019-2023）與預測（2024-2032）

第20章大洋洲壓瘡預防裝置市場（2019-2023）與預測（2024-2032）

第21章中東與非洲壓瘡預防裝置市場（2019-2023年）與預測（2024-2032年）

第22章國家級壓瘡預防裝置市場分析（2022年及2032年）

  • 簡介
    • 主要國家市值比例分析
    • 世界與國家成長比較
  • 美國壓瘡預防設備市場分析
  • 加拿大壓瘡預防裝置市場分析
  • 墨西哥壓瘡預防裝置市場分析
  • 巴西壓瘡預防裝置市場分析
  • 德國壓瘡預防裝置市場分析
  • 義大利壓瘡預防裝置市場分析
  • 法國壓瘡預防裝置市場分析
  • 英國壓瘡預防裝置市場分析
  • 西班牙壓瘡預防裝置市場分析
  • 比荷盧經濟聯盟褥瘡預防裝置市場分析
  • 俄羅斯壓瘡預防裝置市場分析
  • 中國壓瘡預防裝置市場分析
  • 日本壓瘡預防裝置市場分析
  • 韓國壓瘡預防裝置市場分析
  • 印度壓瘡預防裝置市場分析
  • 泰國的褥瘡安防設備市場分析
  • 印尼壓瘡預防裝置市場分析
  • 馬來西亞壓瘡預防裝置市場分析
  • 澳洲壓瘡預防裝置市場分析
  • 紐西蘭壓瘡預防裝置市場分析
  • 海灣合作委員會國家壓瘡預防裝置的市場分析
  • 土耳其壓瘡預防裝置市場分析
  • 北非褥瘡預防裝置市場分析
  • 南非壓瘡預防裝置市場分析

第23章市場結構分析

  • 依公司層級進行市場分析
  • 主要公司市佔率分析
  • 市場現況分析

第 24 章競爭分析

  • 競爭對手儀表板
  • 競爭基準
  • 對競爭對手的深入分析
    • Stryker Corp.
    • Smith &Nephew Plc.
    • Hill-Rom Services Inc.
    • Paramount Bed Holdings Co., Ltd.
    • ArjoHuntleigh
    • Talley Group Limited
    • Drive DeVilbiss Healthcare Ltd（Sidhil Limited）
    • Apex Medical Corp.
    • Medtronic
    • PROMA REHA, sro
    • Linet spol. S RO
    • DARCO International
    • DeRoyal Industries
    • BSN Medical（Essity）
    • Molnlycke Health Care
    • TrueKAST（Wound Kair Concepts）
    • Thuasne SAS
    • DJO Global
    • ORTHOSERVICE AG
    • Breg, Inc.
    • Advanced Orthopaedics
    • ALGEOS
    • Hollister Incorporated
    • ConvaTec Group plc
    • Coloplast A/S
    • Medline Industries Inc.
    • Invacare Corporation

第 25 章先決條件與使用的縮寫

第26章研究方法

簡介目錄
Product Code: PMRREP32831

Persistence Market Research offers a comprehensive analysis of the global pressure ulcer devices market, providing key insights into market dynamics, growth drivers, challenges, and emerging trends. This report offers exclusive data and statistics forecasting the trajectory of the pressure ulcer devices market from 2024 to 2032.

Revenue from the global pressure ulcer devices market reached US$ 5.5 Bn in 2024. With the market projected to expand at a steady 5.5% CAGR, industry valuation is set to top US$ 8.4 Bn by the end of 2032.

Key Insights:

  • Pressure Ulcer Devices Market Size (2024): US$ 5.5 Bn
  • Projected Market Value (2032):US$ 8.4 Bn
  • Global Market Growth Rate (2024-2032):5.5%

Pressure Ulcer Devices Market - Report Scope:

Pressure ulcer devices are essential in preventing and managing pressure ulcers, also known as bedsores or pressure sores, which commonly occur in individuals with limited mobility. These devices include mattresses, cushions, overlays, and specialty beds designed to redistribute pressure, reduce friction, and manage moisture, thus preventing the development of pressure ulcers. The market encompasses a wide range of products catering to various healthcare settings, including hospitals, nursing homes, and home care.

The global pressure ulcer devices market is primarily driven by the increasing prevalence of chronic conditions such as immobility, diabetes, and obesity, which elevate the risk of pressure ulcer development. Additionally, the growing aging population worldwide contributes to the rising demand for pressure ulcer prevention and management solutions. Technological advancements in pressure redistribution surfaces, such as alternating pressure mattresses and low-air-loss mattresses, further fuel market growth by enhancing patient comfort and efficacy in pressure ulcer prevention.

Market Growth Drivers:

The aging population demographic is a significant driver of market growth, as elderly individuals are more susceptible to pressure ulcer development due to factors such as reduced mobility, thinning skin, and comorbidities. With a globally increasing proportion of elderly individuals, particularly in developed regions, the demand for pressure ulcer prevention and management devices is expected to surge.

Moreover, advancements in healthcare infrastructure and increased awareness regarding pressure ulcer prevention among healthcare providers contribute to market expansion. Healthcare facilities are increasingly investing in advanced pressure redistribution surfaces to improve patient outcomes and reduce the economic burden associated with pressure ulcer treatment.

Market Restraints:

One of the key challenges faced by the pressure ulcer devices market is the high cost associated with advanced pressure redistribution surfaces. While these devices offer superior pressure ulcer prevention and management capabilities, their high upfront costs can deter adoption, particularly in healthcare settings with budget constraints.

Additionally, inadequate reimbursement policies for pressure ulcer prevention devices in certain regions hinder market growth. Limited insurance coverage for pressure ulcer prevention and management products reduces their affordability for patients, thereby limiting market penetration.

Market Opportunities:

The growing focus on home-based healthcare and the rise of telemedicine present significant opportunities for the pressure ulcer devices market. As healthcare delivery shifts towards decentralized settings, there is a heightened demand for portable and user-friendly pressure redistribution surfaces suitable for home use. Manufacturers can capitalize on this trend by developing innovative products tailored to the needs of home caregivers and patients.

Furthermore, the integration of smart technologies such as sensors and connectivity features into pressure ulcer devices opens up avenues for remote monitoring and data-driven care. Smart pressure redistribution surfaces equipped with monitoring capabilities enable healthcare providers to track patient compliance, assess risk factors, and intervene proactively, thereby improving clinical outcomes and reducing hospital readmissions.

Key Questions Answered in the Report:

  • Which regions are poised to exhibit the highest demand for pressure ulcer devices?
  • What are the prevailing trends in pressure ulcer prevention and management strategies?
  • How do regulatory frameworks impact the adoption of pressure ulcer devices globally?
  • Who are the key players driving innovation and market expansion in the pressure ulcer devices segment?
  • What are the emerging technological trends shaping the future of the pressure ulcer devices market?

Competitive Intelligence and Business Strategy:

Leading players in the pressure ulcer devices market focus on product innovation, strategic collaborations, and geographical expansion to maintain their competitive edge. Companies invest in research and development to introduce advanced features such as pressure sensing technology, temperature regulation, and antimicrobial properties in their products, enhancing their clinical efficacy and market appeal.

Key Companies Profiled:

  • Stryker Corp.
  • Smith & Nephew Plc.
  • Hill-Rom Services Inc.
  • Paramount Bed Holdings Co., Ltd.
  • ArjoHuntleigh
  • Talley Group Limited
  • Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
  • Apex Medical Corp.
  • Medtronic
  • PROMA REHA, s. r. o.
  • Linet spol. S R.O.
  • DARCO International
  • DeRoyal Industries
  • BSN Medical (Essity)
  • Molnlycke Health Care
  • TrueKAST (Wound Kair Concepts)
  • Thuasne SAS
  • DJO Global
  • ORTHOSERVICE AG
  • Breg, Inc.
  • Advanced Orthopaedics
  • ALGEOS
  • Hollister Incorporated
  • ConvaTec Group plc
  • Coloplast A/S
  • Medline Industries Inc.
  • Invacare Corporation

Pressure Ulcer Devices Market Research Segmentation:

Pressure Ulcer Devices Market by Product:

  • Mattress Overlays
  • Pressure Relief Mattresses

oFoam-based Mattress

oGel-based Mattress

oFiber-filled Mattress

oWater/Fluid-filled Mattress

oAir-filled Mattress

  • Speciality Beds

oKinetic Beds

oAir-Fluidized Beds

  • Pressure Relief Cushions
  • Alternating Pressure Wheelchair's Cushions
  • Off-Loading Devices

oTotal Contact Casting Systems

§Casting System with Boots

§Casting System without Boot

oOff-loading Shoes

§Post-Operative Offloading Shoes

§Wedge-based Shoes

§All Purpose Shoes

§Off-loading insoles

  • Pressure Relief Accessories
  • Advanced Wound Dressings

oAlginate Dressings

oCollagens Dressings

oFilms Dressing

oFoam Dressings

§Anti-microbial Foam Dressing

§Non-Anti-Microbial Foam Dressing

oHydrocolloids Dressing

oHydrofibers Dressings

oHydrogels Dressings

oSuperabsorbent Dressing

oWound Contact Layers

Pressure Ulcer Devices Market by Stage:

  • Stage I Pressure Ulcer Devices
  • Stage II Pressure Ulcer Devices
  • Stage III Pressure Ulcer Devices
  • Stage IV Pressure Ulcer Devices

Pressure Ulcer Devices Market by End User:

  • Hospitals
  • Long-term Care Centres
  • Skilled Nursing Facilities
  • Home Care Settings

Pressure Ulcer Devices Market by Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Value Added Insights

  • 4.1. Pressure Relief Devices Adoption Analysis, By Region
  • 4.2. Disease Epidemiology, By Country
  • 4.3. Key Marketing & Promotional Strategies, By Manufacturers
  • 4.4. Value Chain Analysis
  • 4.5. Regulatory Scenario
  • 4.6. Reimbursement Landscape
  • 4.7. PESTLE Analysis
  • 4.8. Porter's Analysis

5. Specific Insights

  • 5.1. Current PU Prevention Modalities, By End User Settings (ED/Acute Care/ICU's/HDU's/Operating Theatre/Nursing Facilities/Long Term Care/Home Care Settings)
  • 5.2. Role of dressings in pressure ulcer Prevention
  • 5.3. Evidences & Standard of Care of PU preventions, By Setting in Asia Pacific countries
  • 5.4. Current challenges in PU prevention
  • 5.5. Key Trends in PU Prevention, by region

6. Market Background

  • 6.1. Macro-Economic Factors
    • 6.1.1. Global GDP Growth Outlook
    • 6.1.2. Global Healthcare Outlook
  • 6.2. Forecast Factors - Relevance & Impact
    • 6.2.1. Hospital Bed Capacity Per Facility, by Country
    • 6.2.2. Lifespan of Hospital Equipment, Replacement Cycle and New Sales
    • 6.2.3. Adoption of Devices
    • 6.2.4. Prevalence of Pressure Ulcer
    • 6.2.5. Average Cost of Treatment
  • 6.3. Market Dynamics
    • 6.3.1. Drivers
    • 6.3.2. Restraints
    • 6.3.3. Opportunity Analysis

7. COVID19 Crisis Analysis

  • 7.1. Current COVID19 Statistics and Probable Future Impact
  • 7.2. Current GDP Projection and Probable Impact
  • 7.3. COVID19 and Impact Analysis
    • 7.3.1. By Region
    • 7.3.2. By Product
    • 7.3.3. By Stages
    • 7.3.4. By End User

8. Global Pressure Ulcer Devices Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Global Average Pricing Analysis Benchmark

9. Global Pressure Ulcer Devices Market Demand (Volume in thousand units) Analysis 2019-2023 and Forecast, 2024-2032

  • 9.1. Historical Market Volume (Thousand Units) Analysis, 2019-2023
  • 9.2. Current and Future Market Volume (Thousand Units) Projections, 2024-2032
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Pressure Ulcer Devices Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

  • 10.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 10.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
    • 10.2.1. Y-o-Y Growth Trend Analysis

11. Global Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032, by Product

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) and Forecast By Product, 2024-2032
    • 11.3.1. Mattress Overlays
    • 11.3.2. Pressure Relief Mattresses
      • 11.3.2.1. Foam-based Mattress
      • 11.3.2.2. Gel-based Mattress
      • 11.3.2.3. Fiber-filled Mattress
      • 11.3.2.4. Water/Fluid-filled Mattress
      • 11.3.2.5. Air-filled Mattress
    • 11.3.3. Speciality Beds
      • 11.3.3.1. Kinetic Beds
      • 11.3.3.2. Air-Fluidized Beds
    • 11.3.4. Pressure Relief Cushions
    • 11.3.5. Alternating Pressure Wheelchair's Cushions
    • 11.3.6. Off-Loading Devices
      • 11.3.6.1. Total Contact Casting Systems
        • 11.3.6.1.1. Casting System with Boots
        • 11.3.6.1.2. Casting System without Boot
      • 11.3.6.2. Off-loading Shoes
        • 11.3.6.2.1. Post-Operative Offloading Shoes
        • 11.3.6.2.2. Wedge-based Shoes
        • 11.3.6.2.3. All Purpose Shoes
        • 11.3.6.2.4. Off-loading insoles
    • 11.3.7. Pressure Relief Accessories
    • 11.3.8. Advanced Wound Dressings
      • 11.3.8.1. Alginate Dressings
      • 11.3.8.2. Collagens Dressings
      • 11.3.8.3. Films Dressing
      • 11.3.8.4. Foam Dressings
        • 11.3.8.4.1. Anti-microbial Foam Dressing
        • 11.3.8.4.2. Non-Anti-Microbial Foam Dressing
      • 11.3.8.5. Hydrocolloids Dressing
      • 11.3.8.6. Hydrofibers Dressings
      • 11.3.8.7. Hydrogels Dressings
      • 11.3.8.8. Superabsorbent Dressing
      • 11.3.8.9. Wound Contact Layers
  • 11.4. Market Attractiveness Analysis By Product

12. Global Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032, by Stages

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis by Stages, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Stages, 2024-2032
    • 12.3.1. Stage I
    • 12.3.2. Stage II
    • 12.3.3. Stage III
    • 12.3.4. Stage IV
  • 12.4. Market Attractiveness Analysis By Stages

13. Global Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032, by End User

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2032
    • 13.3.1. Hospitals
    • 13.3.2. Long-term Care Centres
    • 13.3.3. Skilled Nursing Facilities
    • 13.3.4. Home Care Settings
  • 13.4. Market Attractiveness Analysis by End User

14. Global Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032, by Region

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2032
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Europe
    • 14.3.4. South Asia
    • 14.3.5. East Asia
    • 14.3.6. Oceania
    • 14.3.7. Middle East and Africa (MEA
  • 14.4. Market Attractiveness Analysis by Region

15. North America Pressure Ulcer Devices Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. U.S.
      • 15.3.1.2. Canada
    • 15.3.2. By Product
    • 15.3.3. By Stages
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Stages
    • 15.4.4. By End User
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis

16. Latin America Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. Brazil
      • 16.3.1.2. Mexico
      • 16.3.1.3. Rest of Latin America
    • 16.3.2. By Product
    • 16.3.3. By Stages
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Stages
    • 16.4.4. By End User
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis

17. Europe Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. Germany
      • 17.3.1.2. Italy
      • 17.3.1.3. France
      • 17.3.1.4. U.K.
      • 17.3.1.5. Spain
      • 17.3.1.6. BENELUX
      • 17.3.1.7. Russia
      • 17.3.1.8. Rest of Europe
    • 17.3.2. By Product
    • 17.3.3. By Stages
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Stages
    • 17.4.4. By End User
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis

18. South Asia Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Thailand
      • 18.3.1.3. Indonesia
      • 18.3.1.4. Malaysia
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product
    • 18.3.3. By Stages
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Stages
    • 18.4.4. By End User
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis

19. East Asia Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 19.3.1. By Country
      • 19.3.1.1. China
      • 19.3.1.2. Japan
      • 19.3.1.3. South Korea
    • 19.3.2. By Product
    • 19.3.3. By Stages
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Stages
    • 19.4.4. By End User
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis

20. Oceania Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 20.3.1. By Country
      • 20.3.1.1. Australia
      • 20.3.1.2. New Zealand
    • 20.3.2. By Product
    • 20.3.3. By Stages
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Stages
    • 20.4.4. By End User
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis

21. Middle East and Africa Pressure Ulcer Devices Market 2019-2023 and Forecast 2024-2032

  • 21.1. Introduction
  • 21.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
  • 21.3. Current and Future Market Size (US$ Mn) Forecast by Market Taxonomy, 2024-2032
    • 21.3.1. By Country
      • 21.3.1.1. GCC Countries
      • 21.3.1.2. Northern Africa
      • 21.3.1.3. South Africa
      • 21.3.1.4. Turkey
      • 21.3.1.5. Rest of Middle East and Africa
    • 21.3.2. By Product
    • 21.3.3. By Stages
    • 21.3.4. By End User
  • 21.4. Market Attractiveness Analysis
    • 21.4.1. By Country
    • 21.4.2. By Product
    • 21.4.3. By Stages
    • 21.4.4. By End User
  • 21.5. Key Market Participants - Intensity Mapping
  • 21.6. Drivers and Restraints - Impact Analysis

22. Country Level Pressure Ulcer Devices Market Analysis 2022 & 2032

  • 22.1. Introduction
    • 22.1.1. Market Value Proportion Analysis, By Key Countries
    • 22.1.2. Global Vs. Country Growth Comparison
  • 22.2. U.S. Pressure Ulcer Devices Market Analysis
    • 22.2.1. By Product
    • 22.2.2. By Stages
    • 22.2.3. By End User
  • 22.3. Canada Pressure Ulcer Devices Market Analysis
    • 22.3.1. By Product
    • 22.3.2. By Stages
    • 22.3.3. By End User
  • 22.4. Mexico Pressure Ulcer Devices Market Analysis
    • 22.4.1. By Product
    • 22.4.2. By Stages
    • 22.4.3. By End User
  • 22.5. Brazil Pressure Ulcer Devices Market Analysis
    • 22.5.1. By Product
    • 22.5.2. By Stages
    • 22.5.3. By End User
  • 22.6. Germany Pressure Ulcer Devices Market Analysis
    • 22.6.1. By Product
    • 22.6.2. By Stages
    • 22.6.3. By End User
  • 22.7. Italy Pressure Ulcer Devices Market Analysis
    • 22.7.1. By Product
    • 22.7.2. By Stages
    • 22.7.3. By End User
  • 22.8. France Pressure Ulcer Devices Market Analysis
    • 22.8.1. By Product
    • 22.8.2. By Stages
    • 22.8.3. By End User
  • 22.9. U.K. Pressure Ulcer Devices Market Analysis
    • 22.9.1. By Product
    • 22.9.2. By Stages
    • 22.9.3. By End User
  • 22.10. Spain Pressure Ulcer Devices Market Analysis
    • 22.10.1. By Product
    • 22.10.2. By Stages
    • 22.10.3. By End User
  • 22.11. BENELUX Pressure Ulcer Devices Market Analysis
    • 22.11.1. By Product
    • 22.11.2. By Stages
    • 22.11.3. By End User
  • 22.12. Russia Pressure Ulcer Devices Market Analysis
    • 22.12.1. By Product
    • 22.12.2. By Stages
    • 22.12.3. By End User
  • 22.13. China Pressure Ulcer Devices Market Analysis
    • 22.13.1. By Product
    • 22.13.2. By Stages
    • 22.13.3. By End User
  • 22.14. Japan Pressure Ulcer Devices Market Analysis
    • 22.14.1. By Product
    • 22.14.2. By Stages
    • 22.14.3. By End User
  • 22.15. South Korea Pressure Ulcer Devices Market Analysis
    • 22.15.1. By Product
    • 22.15.2. By Stages
    • 22.15.3. By End User
  • 22.16. India Pressure Ulcer Devices Market Analysis
    • 22.16.1. By Product
    • 22.16.2. By Stages
    • 22.16.3. By End User
  • 22.17. Thailand Pressure Ulcer Devices Market Analysis
    • 22.17.1. By Product
    • 22.17.2. By Stages
    • 22.17.3. By End User
  • 22.18. Indonesia Pressure Ulcer Devices Market Analysis
    • 22.18.1. By Product
    • 22.18.2. By Stages
    • 22.18.3. By End User
  • 22.19. Malaysia Pressure Ulcer Devices Market Analysis
    • 22.19.1. By Product
    • 22.19.2. By Stages
    • 22.19.3. By End User
  • 22.20. Australia Pressure Ulcer Devices Market Analysis
    • 22.20.1. By Product
    • 22.20.2. By Stages
    • 22.20.3. By End User
  • 22.21. New Zealand Pressure Ulcer Devices Market Analysis
    • 22.21.1. By Product
    • 22.21.2. By Stages
    • 22.21.3. By End User
  • 22.22. GCC Countries Pressure Ulcer Devices Market Analysis
    • 22.22.1. By Product
    • 22.22.2. By Stages
    • 22.22.3. By End User
  • 22.23. Turkey Pressure Ulcer Devices Market Analysis
    • 22.23.1. By Product
    • 22.23.2. By Stages
    • 22.23.3. By End User
  • 22.24. Northern Africa Pressure Ulcer Devices Market Analysis
    • 22.24.1. By Product
    • 22.24.2. By Stages
    • 22.24.3. By End User
  • 22.25. South Africa Pressure Ulcer Devices Market Analysis
    • 22.25.1. By Product
    • 22.25.2. By Stages
    • 22.25.3. By End User

23. Market Structure Analysis

  • 23.1. Market Analysis by Tier of Companies
  • 23.2. Market Share Analysis of Top Players
  • 23.3. Market Presence Analysis
    • 23.3.1. By Regional Footprint of Players
    • 23.3.2. Product Footprint by Players
    • 23.3.3. Channel Footprint by Players

24. Competition Analysis

  • 24.1. Competition Dashboard
  • 24.2. Competition Benchmarking
  • 24.3. Competition Deep Dive
    • 24.3.1. Stryker Corp.
      • 24.3.1.1. Overview
      • 24.3.1.2. Product Portfolio
      • 24.3.1.3. Key Financials
      • 24.3.1.4. Sales Footprint
      • 24.3.1.5. Analyst commentary
      • 24.3.1.6. Strategy Overview
        • 24.3.1.6.1. Marketing Strategy
        • 24.3.1.6.2. Product Strategy
        • 24.3.1.6.3. Channel Strategy
    • 24.3.2. Smith & Nephew Plc.
      • 24.3.2.1. Overview
      • 24.3.2.2. Product Portfolio
      • 24.3.2.3. Key Financials
      • 24.3.2.4. Sales Footprint
      • 24.3.2.5. Analyst commentary
      • 24.3.2.6. Strategy Overview
        • 24.3.2.6.1. Marketing Strategy
        • 24.3.2.6.2. Product Strategy
        • 24.3.2.6.3. Channel Strategy
    • 24.3.3. Hill-Rom Services Inc.
      • 24.3.3.1. Overview
      • 24.3.3.2. Product Portfolio
      • 24.3.3.3. Key Financials
      • 24.3.3.4. Sales Footprint
      • 24.3.3.5. Analyst commentary
      • 24.3.3.6. Strategy Overview
        • 24.3.3.6.1. Marketing Strategy
        • 24.3.3.6.2. Product Strategy
        • 24.3.3.6.3. Channel Strategy
    • 24.3.4. Paramount Bed Holdings Co., Ltd.
      • 24.3.4.1. Overview
      • 24.3.4.2. Product Portfolio
      • 24.3.4.3. Key Financials
      • 24.3.4.4. Sales Footprint
      • 24.3.4.5. Analyst commentary
      • 24.3.4.6. Strategy Overview
        • 24.3.4.6.1. Marketing Strategy
        • 24.3.4.6.2. Product Strategy
        • 24.3.4.6.3. Channel Strategy
    • 24.3.5. ArjoHuntleigh
      • 24.3.5.1. Overview
      • 24.3.5.2. Product Portfolio
      • 24.3.5.3. Key Financials
      • 24.3.5.4. Sales Footprint
      • 24.3.5.5. Analyst commentary
      • 24.3.5.6. Strategy Overview
        • 24.3.5.6.1. Marketing Strategy
        • 24.3.5.6.2. Product Strategy
        • 24.3.5.6.3. Channel Strategy
    • 24.3.6. Talley Group Limited
      • 24.3.6.1. Overview
      • 24.3.6.2. Product Portfolio
      • 24.3.6.3. Key Financials
      • 24.3.6.4. Sales Footprint
      • 24.3.6.5. Analyst commentary
      • 24.3.6.6. Strategy Overview
        • 24.3.6.6.1. Marketing Strategy
        • 24.3.6.6.2. Product Strategy
        • 24.3.6.6.3. Channel Strategy
    • 24.3.7. Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
      • 24.3.7.1. Overview
      • 24.3.7.2. Product Portfolio
      • 24.3.7.3. Key Financials
      • 24.3.7.4. Sales Footprint
      • 24.3.7.5. Analyst commentary
      • 24.3.7.6. Strategy Overview
        • 24.3.7.6.1. Marketing Strategy
        • 24.3.7.6.2. Product Strategy
        • 24.3.7.6.3. Channel Strategy
    • 24.3.8. Apex Medical Corp.
      • 24.3.8.1. Overview
      • 24.3.8.2. Product Portfolio
      • 24.3.8.3. Key Financials
      • 24.3.8.4. Sales Footprint
      • 24.3.8.5. Analyst commentary
      • 24.3.8.6. Strategy Overview
        • 24.3.8.6.1. Marketing Strategy
        • 24.3.8.6.2. Product Strategy
        • 24.3.8.6.3. Channel Strategy
    • 24.3.9. Medtronic
      • 24.3.9.1. Overview
      • 24.3.9.2. Product Portfolio
      • 24.3.9.3. Key Financials
      • 24.3.9.4. Sales Footprint
      • 24.3.9.5. Analyst commentary
      • 24.3.9.6. Strategy Overview
        • 24.3.9.6.1. Marketing Strategy
        • 24.3.9.6.2. Product Strategy
        • 24.3.9.6.3. Channel Strategy
    • 24.3.10. PROMA REHA, s. r. o.
      • 24.3.10.1. Overview
      • 24.3.10.2. Product Portfolio
      • 24.3.10.3. Key Financials
      • 24.3.10.4. Sales Footprint
      • 24.3.10.5. Analyst commentary
      • 24.3.10.6. Strategy Overview
        • 24.3.10.6.1. Marketing Strategy
        • 24.3.10.6.2. Product Strategy
        • 24.3.10.6.3. Channel Strategy
    • 24.3.11. Linet spol. S R.O.
      • 24.3.11.1. Overview
      • 24.3.11.2. Product Portfolio
      • 24.3.11.3. Key Financials
      • 24.3.11.4. Sales Footprint
      • 24.3.11.5. Analyst commentary
      • 24.3.11.6. Strategy Overview
        • 24.3.11.6.1. Marketing Strategy
        • 24.3.11.6.2. Product Strategy
        • 24.3.11.6.3. Channel Strategy
    • 24.3.12. DARCO International
      • 24.3.12.1. Overview
      • 24.3.12.2. Product Portfolio
      • 24.3.12.3. Key Financials
      • 24.3.12.4. Sales Footprint
      • 24.3.12.5. Analyst commentary
      • 24.3.12.6. Strategy Overview
        • 24.3.12.6.1. Marketing Strategy
        • 24.3.12.6.2. Product Strategy
        • 24.3.12.6.3. Channel Strategy
    • 24.3.13. DeRoyal Industries
      • 24.3.13.1. Overview
      • 24.3.13.2. Product Portfolio
      • 24.3.13.3. Key Financials
      • 24.3.13.4. Sales Footprint
      • 24.3.13.5. Analyst commentary
      • 24.3.13.6. Strategy Overview
        • 24.3.13.6.1. Marketing Strategy
        • 24.3.13.6.2. Product Strategy
        • 24.3.13.6.3. Channel Strategy
    • 24.3.14. BSN Medical (Essity)
      • 24.3.14.1. Overview
      • 24.3.14.2. Product Portfolio
      • 24.3.14.3. Key Financials
      • 24.3.14.4. Sales Footprint
      • 24.3.14.5. Analyst commentary
      • 24.3.14.6. Strategy Overview
        • 24.3.14.6.1. Marketing Strategy
        • 24.3.14.6.2. Product Strategy
        • 24.3.14.6.3. Channel Strategy
    • 24.3.15. Molnlycke Health Care
      • 24.3.15.1. Overview
      • 24.3.15.2. Product Portfolio
      • 24.3.15.3. Key Financials
      • 24.3.15.4. Sales Footprint
      • 24.3.15.5. Analyst commentary
      • 24.3.15.6. Strategy Overview
        • 24.3.15.6.1. Marketing Strategy
        • 24.3.15.6.2. Product Strategy
        • 24.3.15.6.3. Channel Strategy
    • 24.3.16. TrueKAST (Wound Kair Concepts)
      • 24.3.16.1. Overview
      • 24.3.16.2. Product Portfolio
      • 24.3.16.3. Key Financials
      • 24.3.16.4. Sales Footprint
      • 24.3.16.5. Analyst commentary
      • 24.3.16.6. Strategy Overview
        • 24.3.16.6.1. Marketing Strategy
        • 24.3.16.6.2. Product Strategy
        • 24.3.16.6.3. Channel Strategy
    • 24.3.17. Thuasne SAS
      • 24.3.17.1. Overview
      • 24.3.17.2. Product Portfolio
      • 24.3.17.3. Key Financials
      • 24.3.17.4. Sales Footprint
      • 24.3.17.5. Analyst commentary
      • 24.3.17.6. Strategy Overview
        • 24.3.17.6.1. Marketing Strategy
        • 24.3.17.6.2. Product Strategy
        • 24.3.17.6.3. Channel Strategy
    • 24.3.18. DJO Global
      • 24.3.18.1. Overview
      • 24.3.18.2. Product Portfolio
      • 24.3.18.3. Key Financials
      • 24.3.18.4. Sales Footprint
      • 24.3.18.5. Analyst commentary
      • 24.3.18.6. Strategy Overview
        • 24.3.18.6.1. Marketing Strategy
        • 24.3.18.6.2. Product Strategy
        • 24.3.18.6.3. Channel Strategy
    • 24.3.19. ORTHOSERVICE AG
      • 24.3.19.1. Overview
      • 24.3.19.2. Product Portfolio
      • 24.3.19.3. Key Financials
      • 24.3.19.4. Sales Footprint
      • 24.3.19.5. Analyst commentary
      • 24.3.19.6. Strategy Overview
        • 24.3.19.6.1. Marketing Strategy
        • 24.3.19.6.2. Product Strategy
        • 24.3.19.6.3. Channel Strategy
    • 24.3.20. Breg, Inc.
      • 24.3.20.1. Overview
      • 24.3.20.2. Product Portfolio
      • 24.3.20.3. Key Financials
      • 24.3.20.4. Sales Footprint
      • 24.3.20.5. Analyst commentary
      • 24.3.20.6. Strategy Overview
        • 24.3.20.6.1. Marketing Strategy
        • 24.3.20.6.2. Product Strategy
        • 24.3.20.6.3. Channel Strategy
    • 24.3.21. Advanced Orthopaedics
      • 24.3.21.1. Overview
      • 24.3.21.2. Product Portfolio
      • 24.3.21.3. Key Financials
      • 24.3.21.4. Sales Footprint
      • 24.3.21.5. Analyst commentary
      • 24.3.21.6. Strategy Overview
        • 24.3.21.6.1. Marketing Strategy
        • 24.3.21.6.2. Product Strategy
        • 24.3.21.6.3. Channel Strategy
    • 24.3.22. ALGEOS
      • 24.3.22.1. Overview
      • 24.3.22.2. Product Portfolio
      • 24.3.22.3. Key Financials
      • 24.3.22.4. Sales Footprint
      • 24.3.22.5. Analyst commentary
      • 24.3.22.6. Strategy Overview
        • 24.3.22.6.1. Marketing Strategy
        • 24.3.22.6.2. Product Strategy
        • 24.3.22.6.3. Channel Strategy
    • 24.3.23. Hollister Incorporated
      • 24.3.23.1. Overview
      • 24.3.23.2. Product Portfolio
      • 24.3.23.3. Key Financials
      • 24.3.23.4. Sales Footprint
      • 24.3.23.5. Analyst commentary
      • 24.3.23.6. Strategy Overview
        • 24.3.23.6.1. Marketing Strategy
        • 24.3.23.6.2. Product Strategy
        • 24.3.23.6.3. Channel Strategy
    • 24.3.24. ConvaTec Group plc
      • 24.3.24.1. Overview
      • 24.3.24.2. Product Portfolio
      • 24.3.24.3. Key Financials
      • 24.3.24.4. Sales Footprint
      • 24.3.24.5. Analyst commentary
      • 24.3.24.6. Strategy Overview
        • 24.3.24.6.1. Marketing Strategy
        • 24.3.24.6.2. Product Strategy
        • 24.3.24.6.3. Channel Strategy
    • 24.3.25. Coloplast A/S
      • 24.3.25.1. Overview
      • 24.3.25.2. Product Portfolio
      • 24.3.25.3. Key Financials
      • 24.3.25.4. Sales Footprint
      • 24.3.25.5. Analyst commentary
      • 24.3.25.6. Strategy Overview
        • 24.3.25.6.1. Marketing Strategy
        • 24.3.25.6.2. Product Strategy
        • 24.3.25.6.3. Channel Strategy
    • 24.3.26. Medline Industries Inc.
      • 24.3.26.1. Overview
      • 24.3.26.2. Product Portfolio
      • 24.3.26.3. Key Financials
      • 24.3.26.4. Sales Footprint
      • 24.3.26.5. Analyst commentary
      • 24.3.26.6. Strategy Overview
        • 24.3.26.6.1. Marketing Strategy
        • 24.3.26.6.2. Product Strategy
        • 24.3.26.6.3. Channel Strategy
    • 24.3.27. Invacare Corporation
      • 24.3.27.1. Overview
      • 24.3.27.2. Product Portfolio
      • 24.3.27.3. Key Financials
      • 24.3.27.4. Sales Footprint
      • 24.3.27.5. Analyst commentary
      • 24.3.27.6. Strategy Overview
        • 24.3.27.6.1. Marketing Strategy
        • 24.3.27.6.2. Product Strategy
        • 24.3.27.6.3. Channel Strategy

25. Assumptions and Acronyms Used

26. Research Methodology